| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.3 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |